MylanLaboratories
| 11:00AM 10/30/2009
While the swine flu pandemic remains a downer for public health officials worldwide, the H1N1 virus proved to be an upper for several pharmaceutical companies' third-quarter earnings. GlaxoSmithKline (GSK), AstraZeneca (AZN) and Sanofi-Aventis (SNY), which make vaccines against the virus, posted...